Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics (Nasdaq: CODX) announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after market close.

Rhea-AI Summary

Co-Diagnostics (Nasdaq: CODX) announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after market close. Management will discuss the results on a conference call and webcast the same day at 4:30 p.m. ET.

The event will feature CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. Investors can access the live webcast via the Events & Webcasts page at ir.co-dx.com or join by phone using the provided toll-free and toll numbers. A replay will later be available on the company’s website.

Argus Jul 30 session 18 alerts

+3.31% close to close 0.2x rel. volume Open Argus

Details

Market move: CODX +3.31% in the Jul 30 session. 2Q26 earnings report

+22.4% Peak Tracked

-2.1% Trough Tracked

$6.02M Market Cap

On Jul 30, the day this news came out, CODX closed 3.31% above the previous close. Argus tracked a peak move of +22.4% during that session. Argus tracked a trough of -2.1% from its starting point during tracking. Our momentum scanner recorded 18 alerts for this stock that day.

Data tracked by StockTitan Argus for the Jul 30 session.

Market Context

The two prior earnings-date announcements were followed by +1.31% and -8.4% reactions, a mixed recor...

Analysis

The two prior earnings-date announcements were followed by +1.31% and -8.4% reactions, a mixed record. The active S-3 is a resale registration; investors can watch the scheduled results for new operating information.

Key Figures

Reporting period: Q2 2026 Release date: August 13, 2026 Webcast time: 4:30 p.m. ET

Reporting period

Q2 2026

Financial results scheduled for release after market close

Release date

August 13, 2026

Second-quarter 2026 financial results

Webcast time

4:30 p.m. ET

Conference call and webcast on August 13, 2026

Previous Earnings date Reports

2 past events · Latest: Apr 30

Same Type 2 events

1. Apr 30

   Earnings date

   24h Move

   +1.3%

   First-quarter 2026 results release date and webcast announced

2. Mar 17

   Earnings date

   24h Move

   -8.4%

   Fourth-quarter and full-year 2025 results release date announced

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its second quarter 2026 financial results on Thursday, August 13, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here

Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-announces-second-quarter-2026-earnings-release-date-and-webcast-302838779.html

SOURCE Co-Diagnostics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Co-Diagnostics (NASDAQ: CODX) release its Q2 2026 earnings?

Co-Diagnostics will release its second quarter 2026 financial results on Thursday, August 13, 2026, after the market close. According to Co-Diagnostics, the earnings release will be followed by a conference call and webcast at 4:30 p.m. ET the same day.

What time is the Co-Diagnostics (CODX) Q2 2026 earnings conference call and webcast?

The Co-Diagnostics Q2 2026 earnings conference call and webcast is scheduled for 4:30 p.m. ET on August 13, 2026. According to Co-Diagnostics, management will discuss the quarterly financial results with analysts immediately following the after-market-close earnings release.

How can investors access the Co-Diagnostics (CODX) Q2 2026 earnings webcast?

Investors can access the Co-Diagnostics Q2 2026 earnings webcast via ir.co-dx.com on the Events & Webcasts page. According to Co-Diagnostics, the webcast will cover management’s discussion of second quarter 2026 financial results on August 13, 2026, at 4:30 p.m. ET.

What are the dial-in numbers for the Co-Diagnostics (CODX) Q2 2026 earnings conference call?

The dial-in numbers are 1-888-880-3330 (toll free) and 1-646-357-8766 (toll). According to Co-Diagnostics, callers can use these numbers to join the second quarter 2026 earnings call on August 13, 2026, at 4:30 p.m. ET.

Will a replay be available for the Co-Diagnostics (CODX) Q2 2026 earnings call?

Yes, a replay of the Co-Diagnostics Q2 2026 earnings call will be available on the company’s website. According to Co-Diagnostics, the live event will be recorded and later posted online for investors who cannot participate in the live webcast.

Who from Co-Diagnostics management will speak on the Q2 2026 earnings call?

Speakers will include CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson. According to Co-Diagnostics, this team will review and discuss the company’s second quarter 2026 financial results with analysts on August 13, 2026.